Bone and glucose metabolism: a two-way street.
Evidence from rodent models indicates that undercarboxylated osteocalcin (ucOC), a product of osteoblasts, is a hormone affecting insulin production by the pancreas and insulin sensitivity in peripheral tissues, at least in part through enhanced secretion of adiponectin from adipocytes. Clinical research to test whether this relationship is found in humans is just beginning to emerge. Cross-sectional studies confirm associations between total osteocalcin (OC), ucOC and glucose metabolism but cannot distinguish causality. To date, longitudinal studies have not provided a consistent picture of the effects of ucOC or OC on fasting glucose and insulin sensitivity. Further exploration into the physiological and mechanistic effects of ucOC and OC, in rodent models and clinical studies, is necessary to determine to what extent the skeleton regulates energy metabolism in humans.
Motyl
Katherine J
KJ
Department of Physiology, Michigan State University, East Lansing, MI 48824, USA.
McCabe
Laura R
LR
Schwartz
Ann V
AV
D000818:Animals; D001842:Bone and Bones / Q000187:drug effects / Q000378:metabolism* / Q000503:physiopathology; D003920:Diabetes Mellitus / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology; D005947:Glucose / Q000378:metabolism*; D006801:Humans; D023421:Models, Animal; D015675:Osteocalcin / Q000378:metabolism
D015675:Osteocalcin; D005947:Glucose